To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Peptidylarginine deiminas… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.

Journal article
Authors Ola Kilsgård
Pia Andersson
Martin Malmsten
Sara L Nordin
Helena M Linge
Mette Eliasson
Eva Sörenson
Jonas S Erjefält
Johan Bylund
Anders I Olin
Ole E Sørensen
Arne Egesten
Published in American journal of respiratory cell and molecular biology
Volume 46
Issue 2
Pages 240-8
ISSN 1535-4989
Publication year 2012
Published at Institute of Medicine, Department of Rheumatology and Inflammation Research
Pages 240-8
Language en
Links dx.doi.org/10.1165/rcmb.2010-0500OC
Keywords Antimicrobial Cationic Peptides, metabolism, physiology, Bronchi, enzymology, Circular Dichroism, Citrulline, metabolism, Electrophoresis, Polyacrylamide Gel, Haemophilus influenzae, physiology, Hydrolases, metabolism, Immunohistochemistry, Inflammation, enzymology, Mass Spectrometry, Proteolysis, Pseudomonas aeruginosa, physiology, Smoking, Staphylococcus aureus, physiology, Streptococcus pneumoniae, physiology, Trachea, enzymology
Subject categories Clinical Medicine

Abstract

Bacterial colonization of the lower respiratory tract is frequently seen in chronic obstructive pulmonary disease (COPD), and may cause exacerbations leading to disease progression. Antimicrobial peptides comprise an important part of innate lung immunity, and not least the cathelicidin human cationic antimicrobial protein-18/LL-37. Peptidylarginine deiminases (PADIs) post-translationally modify proteins by converting cationic peptidylarginine residues to neutral peptidylcitrulline. An increased presence of PADI2 and citrullinated proteins was demonstrated in the lungs of smokers. In this study, preformed PADI4, stored in granulocytes and extracellularly in the lumina of bronchi, was found in lung tissue of individuals suffering from COPD. In vitro, recombinant human PADI2 and PADI4 both caused a time- and dose-dependent citrullination of LL-37. The citrullination resulted in impaired antibacterial activity against Staphylococcus aureus, Streptococcus pneumoniae, and nontypable Haemophilus influenzae, but less so against Pseudomonas aeruginosa. Using artificial lipid bilayers, we observed discrete differences when comparing the disrupting activity of native and citrullinated LL-37, suggesting that differences in cell wall composition are important during interactions with whole bacteria. Furthermore, citrullinated LL-37 showed higher chemotactic activity against mononuclear leukocytes than did native LL-37, but was less efficient at neutralizing lipolysaccharide, and also in converting apoptotic neutrophils into a state of secondary necrosis. In addition, citrullinated LL-37 was more prone to degradation by proteases, whereas the V8 endopetidase of S. aureus cleaved the modified peptide at additional sites, compared with native LL-37. Together, these findings demonstrate novel mechanisms whereby the inflammation-dependent deiminases PADI2 and PADI4 can alter the activites of antibacterial polypeptides, affecting the course of inflammatory disorders such as COPD.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?